PS
Therapeutic Areas
Transition Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| YTHDC1 Inhibitor | MYC-driven cancers | Pre-clinical |
| TDP-43 Collaboration | ALS and Frontotemporal Dementia (FTD) | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| YTHDC1 Inhibitor | MYC-driven cancers | Pre-clinical |
| TDP-43 Collaboration | ALS and Frontotemporal Dementia (FTD) | Discovery |